What is ageing? Even the field's researchers can't agree

Smriti Mallapaty

DOI: https://doi.org/10.1038/d41586-024-03936-8

IF: 64.8

2024-12-04

Nature

Abstract:Survey of scientists who study ageing finds no consensus on the fundamentals. Survey of scientists who study ageing finds no consensus on the fundamentals.

multidisciplinary sciences

What problem does this paper attempt to address?

Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework

Alan A Cohen,Brian K Kennedy,Ulrich Anglas,Anne M Bronikowski,Joris Deelen,Frédérik Dufour,Gerardo Ferbeyre,Luigi Ferrucci,Claudio Franceschi,Daniela Frasca,Bertrand Friguet,Pierrette Gaudreau,Vadim N Gladyshev,Efstathios S Gonos,Vera Gorbunova,Philipp Gut,Mikhail Ivanchenko,Véronique Legault,Jean-François Lemaître,Thomas Liontis,Guang-Hui Liu,Mingxin Liu,Andrea B Maier,Otávio T Nóbrega,Marcel G M Olde Rikkert,Graham Pawelec,Sylvie Rheault,Alistair M Senior,Andreas Simm,Sonja Soo,Annika Traa,Svetlana Ukraintseva,Quentin Vanhaelen,Jeremy M Van Raamsdonk,Jacek M Witkowski,Anatoliy I Yashin,Robert Ziman,Tamàs Fülöp,Alan A. Cohen,Brian K. Kennedy,Anne M. Bronikowski,Vadim N. Gladyshev,Efstathios S. Gonos,Andrea B. Maier,Otávio T. Nóbrega,Marcel G.M. Olde Rikkert,Alistair M. Senior,Jeremy M. Van Raamsdonk,Jacek M. Witkowski,Anatoliy I. Yashin

DOI: https://doi.org/10.1016/j.mad.2020.111316

IF: 5.498

2020-10-01

Mechanisms of Ageing and Development

Abstract:At a recent symposium on aging biology, a debate was held as to whether or not we know what biological aging is. Most of the participants were struck not only by the lack of consensus on this core question, but also on many basic tenets of the field. Accordingly, we undertook a systematic survey of our 71 participants on key questions that were raised during the debate and symposium, eliciting 37 responses. The results confirmed the impression from the symposium: there is marked disagreement on the most fundamental questions in the field, and little consensus on anything other than the heterogeneous nature of aging processes. Areas of major disagreement included what participants viewed as the essence of aging, when it begins, whether aging is programmed or not, whether we currently have a good understanding of aging mechanisms, whether aging is or will be quantifiable, whether aging will be treatable, and whether many non-aging species exist. These disagreements lay bare the urgent need for a more unified and cross-disciplinary paradigm in the biology of aging that will clarify both areas of agreement and disagreement, allowing research to proceed more efficiently. We suggest directions to encourage the emergence of such a paradigm.

cell biology,geriatrics & gerontology,gerontology
Aging research comes of age

Vivien Marx

DOI: https://doi.org/10.1038/s41592-023-02140-2

IF: 48

2024-01-04

Nature Methods

Abstract:As money pours into aging research, the field can combine its many methods to home on what underpins aging. Approaches differ, but researchers share the desire to not overpromise quick-fix anti-aging methods.

biochemical research methods
Aging:A Life Science Approach

Liu Zuyun,Wang Xiaofeng

DOI: https://doi.org/10.3969/j.issn.0368-6396.2013.03.007

IF: 56.9

2013-01-01

Science

Abstract:Aging,a common natural phenomenon of all the organisms,has always been a hot topic in life science research.The mechanism of aging is extremely complicated,involving genetic and environmental factors,as well as their interaction.This paper will make a review of recent research progress of aging with a focus on the research model selection,biomarkers,the mechanisms,and intervention strategies of aging process.
Biological Aging Is No Longer an Unsolved Problem

Leonard Hayflick,L. HAYFLICK

DOI: https://doi.org/10.1196/annals.1395.001

IF: 6.499

2007-04-01

Annals of the New York Academy of Sciences

Abstract:The belief that aging is still an unsolved problem in biology is no longer true. Of the two major classes of theories, the one class that is tenable is derivative of a single common denominator that results in only one fundamental theory of aging. In order to address this complex subject, it is necessary to first define the four phenomena that characterize the finitude of life. These phenomena are aging, the determinants of longevity, age-associated diseases, and death. There are only two fundamental ways in which age changes can occur. Aging occurs either as the result of a purposeful program driven by genes or by events that are not guided by a program but are stochastic or random, accidental events. The weight of evidence indicates that genes do not drive the aging process but the general loss of molecular fidelity does. Potential longevity is determined by the energetics of all molecules present at and after the time of reproductive maturation. Thus, every molecule, including those that compose the machinery involved in turnover, replacement, and repair, becomes the substrate that experiences the thermodynamic instability characteristic of the aging process. However, the determinants of the fidelity of all molecules produced before and after reproductive maturity are the determinants of longevity. This process is governed by the genome. Aging does not happen in a vacuum. Aging must be the result of changes that occur in molecules that have existed at one time with no age changes. It is the state of these pre-existing molecules that governs longevity determination. The distinction between the aging process and age-associated disease is not only based on the molecular definition of aging described above but it is also rooted in several practical observations. Unlike any disease, age changes (a) occur in every multicellular animal that reaches a fixed size at reproductive maturity, (b) cross virtually all species barriers, (c) occur in all members of a species only after the age of reproductive maturation, (d) occur in all animals removed from the wild and protected by humans even when that species probably has not experienced aging for thousands or even millions of years, (e) occur in virtually all animate and inanimate matter, and (f) have the same universal molecular etiology, that is, thermodynamic instability. Unlike aging, there is no disease or pathology that shares these six qualities. Because this critical distinction is poorly understood, there is a continuing belief that the resolution of age-associated diseases will advance our understanding of the fundamental aging process. It will not. The distinction between disease and aging is also critical for establishing science policy because although policy makers understand that the funding of research on age-associated diseases is an unquestioned good, they also must understand that the resolution of age-associated diseases will not provide insights into understanding the fundamental biology of age changes. They often believe that it will and base decisions on that misunderstanding. The impact has been to fund research on age-associated diseases at several orders of magnitude greater than what is available for research on the biology of aging. There is an almost universal belief by geriatricians and others that the greatest risk factor for all of the leading causes of death is old age. Why then are we not devoting significantly greater resources to understanding more about the greatest risk factor for every age-associated pathology by attempting to answer this fundamental question-"What changes occur in biomolecules that lead to the manifestations of aging at higher orders of complexity and then increase vulnerability to all age-associated pathology?"

multidisciplinary sciences
Ageing as a two-phase process: theoretical framework

Flaminia Zane,Claire MacMurray,Clémence Guillermain,Céline Cansell,Nicolas Todd,Michael Rera

DOI: https://doi.org/10.3389/fragi.2024.1378351

2024-04-08

Abstract:Human ageing, along with the ageing of conventional model organisms, is depicted as a continuous and progressive decline of biological capabilities accompanied by an exponentially increasing mortality risk. However, not all organisms experience ageing identically and our understanding of the phenomenon is coloured by human-centric views. Ageing is multifaceted and influences a diverse range of species in varying ways. Some undergo swift declines post-reproduction, while others exhibit insubstantial changes throughout their existence. This vast array renders defining universally applicable "ageing attributes" a daunting task. It is nonetheless essential to recognize that not all ageing features are organism-specific. These common attributes have paved the way for identifying "hallmarks of ageing," processes that are intertwined with age, amplified during accelerated ageing, and manipulations of which can potentially modulate or even reverse the ageing process. Yet, a glaring observation is that individuals within a single population age at varying rates. To address this, demographers have coined the term 'frailty'. Concurrently, scientific advancements have ushered in the era of molecular clocks. These innovations enable a distinction between an individual's chronological age (time since birth) and biological age (physiological status and mortality risk). In 2011, the "Smurf" phenotype was unveiled in Drosophila, delineating an age-linked escalation in intestinal permeability that presages imminent mortality. It not only acts as a predictor of natural death but identifies individuals exhibiting traits normally described as age-related. Subsequent studies have revealed the phenotype in organisms like nematodes, zebrafish, and mice, invariably acting as a death predictor. Collectively, these findings have steered our conception of ageing towards a framework where ageing is not linear and continuous but marked by two distinct, necessary phases, discernible in vivo, courtesy of the Smurf phenotype. This framework includes a mathematical enunciation of longevity trends based on three experimentally measurable parameters. It facilitates a fresh perspective on the evolution of ageing as a function. In this article, we aim to delineate and explore the foundational principles of this innovative framework, emphasising its potential to reshape our understanding of ageing, challenge its conventional definitions, and recalibrate our comprehension of its evolutionary trajectory.
Forever young: what science can and can't tell us about cheating ageing

Jan H. J. Hoeijmakers

DOI: https://doi.org/10.1038/d41586-024-02677-y

IF: 64.8

2024-08-23

Nature

Abstract:High-profile advances, such as anti-ageing drugs called senolytics, have sparked hope that old age and death could be postponed considerably, and have even fostered fantasies of eternal life. But the reality is more nuanced. High-profile advances, such as anti-ageing drugs called senolytics, have sparked hope that old age and death could be postponed considerably, and have even fostered fantasies of eternal life. But the reality is more nuanced.

multidisciplinary sciences
Ageing in Plants: Conserved Strategies and Novel Pathways

H.-C. Jing,J. Hille,P. P. Dijkwel

DOI: https://doi.org/10.1055/s-2003-44779

2003-09-01

Plant Biology

Abstract:Ageing increases chaos and entropy and ultimately leads to the death of living organisms. Nevertheless, single gene mutations substantially alter lifespan, revealing that ageing is subject to genetic control. In higher plants, ageing is most obviously manifested by the senescence of leaves, and recent molecular genetic studies, in particular the isolation of Arabidopsis mutants with altered leaf senescence, have greatly advanced our understanding of ageing regulation in plants. This paper provides an overview of the identified genes and their respective molecular pathways. Hormones, metabolic flux, reactive oxygen species and protein degradation are prominent strategies employed by plants to control leaf senescence. Plants predominantly use similar ageing-regulating strategies as yeast and animals but have evolved different molecular pathways. The senescence window concept is proposed to describe the age-dependent actions of the regulatory genes. It is concluded that the similarities and differences in ageing between plants and other organisms are deeply rooted in the evolution of ageing and we hope to stimulate discussion and research in the fascinating field of leaf senescence.

plant sciences
Quantification of biological aging in young adults

Daniel W. Belsky,Avshalom Caspi,Renate Houts,Harvey J. Cohen,David L. Corcoran,Andrea Danese,HonaLee Harrington,Salomon Israel,Morgan E. Levine,Jonathan D. Schaefer,Karen Sugden,Ben Williams,Anatoli I. Yashin,Richie Poulton,Terrie E. Moffitt

DOI: https://doi.org/10.1073/pnas.1506264112

IF: 11.1

2015-07-06

Proceedings of the National Academy of Sciences

Abstract:Significance The global population is aging, driving up age-related disease morbidity. Antiaging interventions are needed to reduce the burden of disease and protect population productivity. Young people are the most attractive targets for therapies to extend healthspan (because it is still possible to prevent disease in the young). However, there is skepticism about whether aging processes can be detected in young adults who do not yet have chronic diseases. Our findings indicate that aging processes can be quantified in people still young enough for prevention of age-related disease, opening a new door for antiaging therapies. The science of healthspan extension may be focused on the wrong end of the lifespan; rather than only studying old humans, geroscience should also study the young.
Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

Daniel W Belsky,Terrie E Moffitt,Alan A Cohen,David L Corcoran,Morgan E Levine,Joseph A Prinz,Jonathan Schaefer,Karen Sugden,Benjamin Williams,Richie Poulton,Avshalom Caspi,Daniel W. Belsky,Terrie E. Moffitt,Alan A. Cohen,David L. Corcoran,Morgan E. Levine,Joseph A. Prinz

DOI: https://doi.org/10.1093/aje/kwx346

2017-11-15

American Journal of Epidemiology

Abstract:The geroscience hypothesis posits that therapies to slow biological processes of aging can prevent disease and extend healthy years of life. To test such "geroprotective" therapies in humans, outcome measures are needed that can assess extension of disease-free life span. This need has spurred development of different methods to quantify biological aging. But different methods have not been systematically compared in the same humans. We implemented 7 methods to quantify biological aging using repeated-measures physiological and genomic data in 964 middle-aged humans in the Dunedin Study (New Zealand; persons born 1972-1973). We studied 11 measures in total: telomere-length and erosion, 3 epigenetic-clocks and their ticking rates, and 3 biomarker-composites. Contrary to expectation, we found low agreement between different measures of biological aging. We next compared associations between biological aging measures and outcomes that geroprotective therapies seek to modify: physical functioning, cognitive decline, and subjective signs of aging, including aged facial appearance. The 71-cytosine-phosphate-guanine epigenetic clock and biomarker composites were consistently related to these aging-related outcomes. However, effect sizes were modest. Results suggested that various proposed approaches to quantifying biological aging may not measure the same aspects of the aging process. Further systematic evaluation and refinement of measures of biological aging is needed to furnish outcomes for geroprotector trials.

public, environmental & occupational health
Ethical concerns in aging research: perspectives of global frontline researchers

Yaojin Peng,Lulu Ding,Zhenyu Xiao,Moshi Song,Jianwei Lv,Guang-Hui Liu

DOI: https://doi.org/10.1007/s11427-024-2650-y

Abstract:This study investigated the ethical landscape of aging research amid the increasing global focus on extending the human lifespan and health span. Our global survey of 180 researchers across 38 jurisdictions revealed divergent perceptions of aging, a consensus regarding the feasibility of delaying aging, and multiple perspectives regarding lifespan extension. The present findings underscore a paradigm shift toward inclusive and ethically sound research, emphasizing the need for an approach that strikes a balance between basic and clinical research. In addition, this study highlighted key ethical concerns in aging research, including the effects of misleading advertising, potential inequality in access to aging interventions, and risks pertaining to the extrapolation of research findings from lower-model organisms to humans. The insights presented in this paper call for an integrated approach for overcoming the complex ethical and societal challenges in aging research to ensure responsible and equitable advancements in this burgeoning field.
Daily briefing: Can scientists ever agree on how consciousness works?

Flora Graham

DOI: https://doi.org/10.1038/d41586-024-00153-1

IF: 64.8

2024-01-17

Nature

Abstract:Projects to test competing theories of consciousness are raising hopes that we’re making progress on one of science’s most intractable questions. Plus, a cloned rhesus monkey lives to adulthood for first time and what a 92-year-old elite athlete teaches us about healthy ageing.

multidisciplinary sciences
Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise

Rumiana Tenchov,Janet M. Sasso,Xinmei Wang,Qiongqiong Angela Zhou

DOI: https://doi.org/10.1021/acschemneuro.3c00532

2024-01-12

ACS Chemical Neuroscience

Abstract:Aging is typified by a gradual loss of physiological fitness and accumulation of cellular damage, leading to deteriorated functions and enhanced vulnerability to diseases. Antiaging research has a long history throughout civilization, with many efforts put forth to understand and prevent the effects of aging. Multiple strategies aiming to promote healthy aging and extend the lifespan have been developed including lifestyle adjustments, medical treatments, and social programs. A multitude of antiaging medicines and remedies have also been explored. Here, we use data from the CAS Content Collection to analyze the publication landscape of recent research related to antiaging strategies and treatments. We review the recent advances and delineate trends in research headway of antiaging knowledge and practice across time, geography, and development pipelines. We further assess the state-of-the-art antiaging approaches and explore their correlations with age-related diseases. The landscape of antiaging drugs has been outlined and explored. Well-recognized and novel, currently evaluated antiaging agents have also been summarized. Finally, we review clinical applications of antiaging products with their development pipelines. The objective of this review is to summarize current knowledge on preventive strategies and treatment remedies in the field of aging, to outline challenges and evaluate growth opportunities, in order to further efforts to solve the problems that remain.

biochemistry & molecular biology,chemistry, medicinal,neurosciences
Aging Scientists and Slowed Advance

Haochuan Cui,Lingfei Wu,James A. Evans

DOI: https://doi.org/10.48550/arXiv.2202.04044

2022-02-08

Digital Libraries

Abstract:What is the relationship between aging and the character of scientific advance? Prior research focuses on star scientists, their changing dates, and rates of breakthrough success through history. Analyzing more than 244 million scholars across 241 million articles over the last two centuries, we show that for all fields, periods, and impact levels, scientists research ideas and references age over time, their research is less likely to disrupt the state of science and more likely to criticize emerging work. Early success accelerates scientist aging; while changing institutions and fields and collaborating with young scientists slows it. These patterns aggregate within fields such that those with a higher proportion of older scientists experience a lower churn of ideas and more rapid individual aging, suggesting a universal link between aging, activity, and advance.
Can ageing be stopped? A biologist explains

Benjamin Thompson

DOI: https://doi.org/10.1038/d41586-024-02713-x

IF: 64.8

2024-08-24

Nature

Abstract:Nobel laureate Venki Ramakrishnan joins us to talk about his book Why We Die: The New Science of Ageing and the Quest for Immortality. Venki Ramakrishnan talks to Nature about the science of ageing.

multidisciplinary sciences
A synopsis on aging-Theories, mechanisms and future prospects

João Pinto da Costa,Rui Vitorino,Gustavo M Silva,Christine Vogel,Armando C Duarte,Teresa Rocha-Santos

DOI: https://doi.org/10.1016/j.arr.2016.06.005

Abstract:Answering the question as to why we age is tantamount to answering the question of what is life itself. There are countless theories as to why and how we age, but, until recently, the very definition of aging - senescence - was still uncertain. Here, we summarize the main views of the different models of senescence, with a special emphasis on the biochemical processes that accompany aging. Though inherently complex, aging is characterized by numerous changes that take place at different levels of the biological hierarchy. We therefore explore some of the most relevant changes that take place during aging and, finally, we overview the current status of emergent aging therapies and what the future holds for this field of research. From this multi-dimensional approach, it becomes clear that an integrative approach that couples aging research with systems biology, capable of providing novel insights into how and why we age, is necessary.
Does the human lifespan have a limit?

Michael Eisenstein

DOI: https://doi.org/10.1038/d41586-022-00070-1

IF: 64.8

2022-01-19

Nature

Abstract:Super-centenarians offer clues as demographers and scientists lock horns over one of the world’s oldest research questions.

multidisciplinary sciences
Evolution of ageing as a tangle of trade-offs: energy versus function

Alexei A. Maklakov,Tracey Chapman

DOI: https://doi.org/10.1098/rspb.2019.1604

2019-09-18

Proceedings of the Royal Society B: Biological Sciences

Abstract:Despite tremendous progress in recent years, our understanding of the evolution of ageing is still incomplete. A dominant paradigm maintains that ageing evolves due to the competing energy demands of reproduction and somatic maintenance leading to slow accumulation of unrepaired cellular damage with age. However, the centrality of energy trade-offs in ageing has been increasingly challenged as studies in different organisms have uncoupled the trade-off between reproduction and longevity. An emerging theory is that ageing instead is caused by biological processes that are optimized for early-life function but become harmful when they continue to run-on unabated in late life. This idea builds on the realization that early-life regulation of gene expression can break down in late life because natural selection is too weak to optimize it. Empirical evidence increasingly supports the hypothesis that suboptimal gene expression in adulthood can result in physiological malfunction leading to organismal senescence. We argue that the current state of the art in the study of ageing contradicts the widely held view that energy trade-offs between growth, reproduction, and longevity are the universal underpinning of senescence. Future research should focus on understanding the relative contribution of energy and function trade-offs to the evolution and expression of ageing.
The stress of aging

Matteo Cesari,Bruno Vellas,Giovanni Gambassi

DOI: https://doi.org/10.1016/j.exger.2012.10.004

Abstract:Although the evolutionary theories of aging are quite well established, our knowledge about how we age is still very limited. The abundance and heterogeneity of available mechanistic theories of aging implicitly suggest that this phenomenon is overly complex and unlikely to be explained by a single pathway. Moreover, although aging remains a unique process, it is characterized by heterogeneous manifestations, not only determining inter-individual variations, but even intra-individual diversities. Such heterogeneity renders the inner nature of the aging process of difficult evaluation in older persons due to the potential biases introduced by multiple age-related social, biological, and clinical factors (and responsible for the evidence-based issue in geriatrics). Moving from the difficulties in translating anti-aging preclinical interventions into clinical trials, an alternative approach is illustrated. We encourage moving to a holistic evaluation of aging by adopting specific and consequent modifications in the design and conduction of clinical research. Such approach is today commonly applied in the clinical setting where the complexity of older patients often requires multidimensional interventions to adequately target the geriatric syndromes. Consistently, interventions targeting the aging process may result ineffective if too focused on a single underlying causal mechanism and/or failing to capture the complexity of the phenomenon. In this context, frailty (a geriatric syndrome characterized by age-related declines occurring across multiple physiologic systems) may indeed represent a clinically relevant threshold throughout the continuum of the aging process and a promising benchmark to test multidomain interventions against age-related conditions.
The Longitudinal Study of Aging in Human Young Adults: Knowledge Gaps and Research Agenda

Terrie E Moffitt,Daniel W Belsky,Andrea Danese,Richie Poulton,Avshalom Caspi,Terrie E. Moffitt,Daniel W. Belsky

DOI: https://doi.org/10.1093/gerona/glw191

2016-10-07

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Abstract:BACKGROUND: To prevent onset of age-related diseases and physical and cognitive decline, interventions to slow human aging and extend health span must eventually be applied to people while they are still young and healthy. Yet most human aging research examines older adults, many with chronic disease, and little is known about aging in healthy young humans.METHOD: This article explains how this knowledge gap is a barrier to extending health span and puts forward the case that geroscience should invest in researching the pace of aging in young adults. As one illustrative example, we describe an initial effort to study the pace of aging in a young-adult birth cohort by using repeated waves of biomarkers collected across the third and fourth decades to quantify the pace of coordinated physiological deterioration across multiple organ systems (eg, pulmonary, periodontal, cardiovascular, renal, hepatic, metabolic, and immune function).RESULTS: Findings provided proof of principle that it is possible to quantify individual variation in the pace of aging in young adults still free of age-related diseases.CONCLUSIONS: This article articulates research needs to improve longitudinal measurement of the pace of aging in young people, to pinpoint factors that slow or speed the pace of aging, to compare pace of aging against genomic clocks, to explain slow-aging young adults, and to apply pace of aging in preventive clinical trials of antiaging therapies. This article puts forward a research agenda to fill the knowledge gap concerning lifelong causes of aging.
MDSCs, ageing and inflammageing

Graham Pawelec,Emilie Picard,Valquiria Bueno,Chris P Verschoor,Suzanne Ostrand-Rosenberg,Chris P. Verschoor

DOI: https://doi.org/10.1016/j.cellimm.2021.104297

IF: 4.178

2021-04-01

Cellular Immunology

Abstract:<p>The challenge of distinguishing between changes attributable to ageing and those attributable to pathology is even greater for the immune system than for many other organs, and this is especially true for myeloid-derived suppressor cells (MDSCs). Hematopoiesis is different in older adults with a bias towards myelopoiesis, and older adults also manifest "inflammageing" exacerbated by disease and contributing to MDSC induction. Hence, at least in humans, one can only investigate MDSCs in the context of ageing and disease states, and not in the context of ageing processes per se. This contribution provides a brief overview of the literature on MDSCs and ageing in humans.</p>

immunology,cell biology

What is ageing? Even the field's researchers can't agree

Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework

Aging research comes of age

Aging:A Life Science Approach

Biological Aging Is No Longer an Unsolved Problem

Ageing as a two-phase process: theoretical framework

Forever young: what science can and can't tell us about cheating ageing

Ageing in Plants: Conserved Strategies and Novel Pathways

Quantification of biological aging in young adults

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

Ethical concerns in aging research: perspectives of global frontline researchers

Daily briefing: Can scientists ever agree on how consciousness works?

Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise

Aging Scientists and Slowed Advance

Can ageing be stopped? A biologist explains

A synopsis on aging-Theories, mechanisms and future prospects

Does the human lifespan have a limit?

Evolution of ageing as a tangle of trade-offs: energy versus function

The stress of aging

The Longitudinal Study of Aging in Human Young Adults: Knowledge Gaps and Research Agenda

MDSCs, ageing and inflammageing